Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010

Virology Journal

Volumn 8, Issue , 2011, Pages

  De Felipe, Beatriz ^a   Pérez Romero, Pilar ^a   Abad Fernández, María ^b   Fernandez Cuenca, Felipe ^c   Martinez Fernandez, Francisco J ^a   Trastoy, Mánica ^a   Mata, Rosario ^a   Lápez Cortés, Luis F ^a   Leal, Manuel ^a   Viciana, Pompeyo ^a   Vallejo, Alejandro ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Hospital Universitario Ramán y Cajal   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

immigrant; non B HIV 1 subtypes; resistance mutation; Spain

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; P16 PROTEASE, HUMAN IMMUNODEFICIENCY VIRUS 1; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; AFRICA; ARTICLE; CENTRAL AMERICA; CODON; DATA BASE; EUROPE; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC RECOMBINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE A; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE B C; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE CRF01 AE; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE CRF02 AG; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE CRF02 AG CRF01 AE; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE CRF2 AG G; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE F; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE F B; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE G; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE J; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE K; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE K G; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMIGRANT; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NON B HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE; NUCLEOTIDE SEQUENCE; PHYLOGENY; SOUTH AMERICA; SPAIN; VIRUS GENE; VIRUS MUTANT; VIRUS RESISTANCE; VIRUS STRAIN; ANTIVIRAL RESISTANCE; CLUSTER ANALYSIS; DNA SEQUENCE; DRUG EFFECT; GENETICS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MIGRATION; MISSENSE MUTATION; MOLECULAR GENETICS; PREVALENCE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTI-HIV AGENTS; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; EMIGRANTS AND IMMIGRANTS; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; PREVALENCE; SEQUENCE ANALYSIS, DNA; SPAIN;

EID: 80052037531     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-416     Document Type: Article

References (28)

1. Increasing HIV-1 genetic diversity in Europe. Thomson M, Najera R, J Infect Dis 2007 196 1120 1124 10.1086/521683 17955428 (Pubitemid 47580265)
2. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, Sema H, Tshimanga K, Bongo B, Delaporte E, J Virol 2000 74 10498 10507 10.1128/JVI.74.22.10498-10507.2000 11044094
3. HIV-1 subtypes: epidemiology and significance for HIV management. Geretti AM, Curr Opin Infect Dis 2006 19 1 7 10.1097/01.qco.0000200293.45532.68 16374210 (Pubitemid 43032432)
4. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. Hemelaar J, Gouws E, Ghys PD, Osmanov S, AIDS 2006 20 13 23 10.1097/01.aids.0000247564.73009.bc 17053344 (Pubitemid 44611051)
5. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. Balotta C, Facchi G, Violin M, Van Dooren S, Cozzi-Lepri A, Forbici F, Bertoli A, Riva C, Senese D, Caramello P, Carnevale G, Rizzardini G, Cremonini L, Monno L, Rezza G, Perno CF, Ippolito G, d'Arminio-Monforte A, Vandamme AM, Moroni M, ICONA Study Group, J Acquir Immune Defic Syndr 2001 27 499 505 11511828 (Pubitemid 32801080)
6. Epidemiology of HIV-1 subtypes in an urban area of northern Italy. De Paschale M, Cagnin D, Cerulli T, Mena M, Magnani C, Perini P, Re T, Villa M, Vigan P, Maltempo C, Manco MT, Agrappi C, Mirri P, Gatti A, Rescaldani C, Clerici P, Clin Microbiol Infect 2011 17 935 940 10.1111/j.1469-0691.2010.03382. x 20874813
7. Genetic Subtypes of HIV Type 1 Circulating in Slovakia. Habekova M, Takacova M, Lysy J, Mokras M, Camacho R, Truska P, Stanekova D, AIDS Res Human Retroviruses 2010 26 1103 1107 10.1089/aid.2009.0220
8. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, Fawzi W, Hunter D, Clin Infect Dis 2006 42 843 852 10.1086/499952 16477563 (Pubitemid 43363943)
9. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH, AIDS 2009 18 2479 2484
10. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France. Descamps D, Chaix ML, Montes B, Pakianather S, Charpentier C, Storto A, Barin F, Dos Santos G, Krivine A, Delaugerre C, Izopet J, Marcelin AG, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Tamalet C, Cottalorda J, Desbois D, Calvez V, Brun-Vezinet F, Masquelier B, Costagliola D, the ANRS AC11 Resistance Study Group, J Antimicrob Chemother 2010 65 2620 2627 10.1093/jac/dkq380 20965891
11. Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda. Eshleman SH, Laeyendecker O, Parkin N, Huang W, Chappey C, Paquet AC, Serwadda D, Reynolds SJ, Kiwanuka N, Quinn TC, Gray R, Wawer M, AIDS 2009 27 845 852 10.1097/QAD.0b013e328327957a
12. Characterization of mutations in CRF01-AE virus isolates from antiretroviral treatment-naive and -experienced patients in Singapore. Hsu LY, Subramaniam R, Bacheler L, Paton NI, J Acquir Immune Defic Syndr 2005 38 5 13 10.1097/00126334-200501010-00002 15608517 (Pubitemid 40094111)
13. Drug resistance in non-subtype B HIV-1. Kantor R, Katzenstein D, J Clin Virol 2004 29 152 159 10.1016/S1386-6532(03)00115-X 14962783 (Pubitemid 38201460)
14. Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays. Peeters M, Aghokeng AF, Delaporte E, Clin Microbiol Infection 2010 16 1525 1531 10.1111/j.1469-0691.2010.03300.x
15. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. Wheeler WH, Ziebell RA, Zabina H, Pieniazek D, Prejean J, Bodnar UR, Mahle KC, Heneine W, Johnson JA, Hall HI, the Variant and Resistant HIV Surveillance Group, AIDS 2010 24 1203 1212 10.1097/QAD.0b013e3283388742 20395786
16. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients. Vergne L, Stuyver L, Van Houtte M, Butel C, Delaporte E, Peeters M, J Clin Virol 2006 36 43 49 10.1016/j.jcv.2006.01.012 16563858 (Pubitemid 44382730)
17. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. Gueudin M, Plantier JC, Lemée V, Schmitt MP, Chartier L, Bourlet T, Ruffault A, Damond F, Vray M, Simon F, J Acquir Immune Defic Syndr 2007 44 500 505 10.1097/QAI. 0b013e31803260df 17259908 (Pubitemid 46594892)
18. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, Peeters M, Damond F, Ekouevi DK, Msellati P, Ferradini L, Rukobo S, Maréchal V, Schvachsa N, Wakrim L, Rafalimanana C, Rakotoambinina B, Viard JP, Seigneurin JM, Rouzioux C, J Acquir Immune Defic Syndr 2007 45 380 388 10.1097/QAI.0b013e3180640cf5 17468666 (Pubitemid 47057665)
19. HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe. Holguín A, Alvarez A, Pena MJ, Artiles F, Molina L, Soriano V, HIV Clin Trials 2003 4 184 192 10.1310/9X1G-MJ6L-PBJN-1PVE 12815558 (Pubitemid 36748623)
20. Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. Holguín A, de Mulder M, Yebra G, Lápez M, Soriano V, Curr HIV Res 2008 6 327 334 10.2174/ 157016208785132455 18691031
21. HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. Lospitao E, Alvarez A, Soriano V, Holguín A, HIV Med 2005 6 313 320 10.1111/j.1468-1293.2005.00313.x 16156878 (Pubitemid 41335139)
22. Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain. Trevĩo A, Soriano V, Rodriguez C, Arredondo M, Rivas P, Herrero-Mendoza D, Parra P, del Romero J, Anta L, Puente S, de Mendoza C, AIDS Res Hum Retroviruses 2011 27 633 638 10.1089/aid.2010.0247 21039316
23. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW, PLoS One 2009 4 4724 10.1371/journal.pone.0004724 19266092
24. Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B. Montes B, Vergne L, Peeters M, Reynes J, Delaporte E, Segondy M, J Acquir Immune Defic Syndr 2004 35 329 336 10.1097/00126334-200404010-00001 15097148 (Pubitemid 38332792)
25. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. Drexler JF, de Souza Luna LK, Pedroso C, Pedral-Sampaio DB, Queiroz AT, Brites C, Netto EM, Drosten C, J Clin Microbiol 2007 45 2061 2063 10.1128/JCM.00136-07 17392448 (Pubitemid 46933963)
26. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmission. Geelen S, Lange J, Borleffs J, Wolfs T, Weersink A, Schuurman R, AIDS 2003 17 781 778 10.1097/00002030-200303280-00027 12646812 (Pubitemid 36521095)
27. Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain. McConnell MJ, Docobo-Pérez F, Mata RC, Fernandez-Cuenca F, Viciana P, Lápez-Cortés LF, Trastoy M, Pachán J, Pérez-Romero P, AIDS Res Hum Retroviruses 2008 24 881 887 10.1089/aid.2008.0051 18572440 (Pubitemid 351871678)
28. Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment nave HIV-infected individuals (CoRIS). García F, Pérez-Cachafeiro S, Guillot V, Alvarez M, Pérez-Romero P, Pérez-Elías MJ, Viciana I, Blanco JR, Lápez-Dieguez M, de Mendoza C, Cohort of the Spanish AIDS Research Network (CoRIS), Antiviral Res 2011 91 150 153 10.1016/j.antiviral.2011.05.010 21663768